author-photo

Vincent A. Miller

Memorial Sloan Kettering Cancer Center
Cornell University

119

Papers

19070

Citations

Citation Trend

Filter By

Papers (119) Sort By

JournalConferenceOthers

Exceptional responders with invasive mucinous adenocarcinomas: a phase 2 trial of bortezomib in patients with KRAS G12D-mutant lung cancers

2019
Show All
- Source
- Cite
- Save
Citations (11)
Large-Cell Neuroendocrine Carcinoma of the Lung: A Focused Analysis of BRAF Alterations and Case Report of a BRAF Non-V600–Mutated Tumor Responding to Targeted Therapy

2018
Show All
- Source
- Cite
- Save
Citations (2)
BRAF in Lung Cancers: Analysis of Patient Cases Reveals Recurrent BRAF Mutations, Fusions, Kinase Duplications, and Concurrent Alterations

2018
Show All
- Source
- Cite
- Save
Citations (14)
Durable Clinical Response to Larotrectinib in an Adolescent Patient With an Undifferentiated Sarcoma Harboring an STRN-NTRK2 Fusion

2018
Show All
- Source
- Cite
- Save
Citations (3)
Response to rapamycin analogs but not PD-1 inhibitors in PTEN-mutated metastatic non-small-cell lung cancer with high tumor mutational burden

2018
Show All
- Source
- Cite
- Save
Citations (7)
A phase I dose-escalation study of the HSP90 inhibitor AUY922 and erlotinib for patients with EGFR-mutant lung cancer with acquired resistance (AR) to EGFR tyrosine kinase inhibitors (EGFR TKIs).

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (5)
Response of a Metastatic Breast Carcinoma With a Previously Uncharacterized ERBB2 G776V Mutation to Human Epidermal Growth Factor Receptor 2–Targeted Therapy

2017
Show All
- Source
- Cite
- Save
Citations (0)
Phase IIb/III double-blind randomized trial of BIBW 2992, an irreversible, dual inhibitor of EGFR and HER2 plus best supportive care (BSC) versus placebo plus BSC in patients with NSCLC failing 1–2 lines of chemotherapy (CT) and erlotinib or gefitinib (LUX- Lung1): A preliminary report

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (35)
Genomic Profiling of Advanced-Stage, Metaplastic Breast Carcinoma by Next-Generation Sequencing Reveals Frequent, Targetable Genomic Abnormalities and Potential New Treatment Options

2015
Show All
- Source
- Cite
- Save
Citations (0)
NewChemotherapeutic Agentsfor Non-small CellLungCancer*

2015
Show All
- Source
- Cite
- Save
Citations (0)

© Copyright 2015-2020 Acemap, Inc. Shanghai Jiao Tong University.

沪ICP备18028330号